Marksans Pharma Limited (MARKSANS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 71.11B |
| Enterprise Value | 68.2B |
| P/E Ratio | 25.89 |
| PEG Ratio | 0.44 |
| Price/Sales Ratio | 4.28 |
| Price/Book Ratio | 4.35 |
| Enterprise/Revenue | 4.1 |
| Enterprise/EBITDA | 17.3 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 29.51B |
| Revenue/Share | 74.84 |
| Gross Profit | 11.57B |
| EBITDA | 6.03B |
| Net Income | 4.18B |
| Diluted EPS | 9.22 |
Balance Sheet
| Total Cash | 11.24B |
| Total Cash/Share | 24.8 |
| Total Debt | 4.65B |
| Total Debt/Equity | 0.14 |
| Current Ratio | 5.02 |
| Book Value Per Share | 74.31 |
Price History
| 52-Week Change | 62.5 |
| 52-Week High | 350.95 |
| 52-Week Low | 155 |
| Moving Average 50 Days | 317.51 |
| Moving Average 200 Days | 249.13 |
Statistics
| Average Volume | 2.58M |
| Shares Outstanding | 453.16M |
| % Held by Institutions | 0.14 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.9 |
| Trailing Annual Dividend Yield | 0.28 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | March 11, 2008 |
AD
